Compound 681
Identifiers
- Canonical SMILES:
CC(C)CN(Cc1cc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc(Oc2ccc(F)cc2)c1)S(=O)(=O)c1ccc(C)cc1
- IUPAC name:
3,5-dichloro-N-[[3-(4-fluorophenoxy)-5-[[(4-methylphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide
- InChi:
InChI=1S/C38H36Cl2F2N2O6S2/c1-25(2)21-43(51(46,47)35-14-4-26(3)5-15-35)23-28-16-29(18-34(17-28)50-33-12-10-32(42)11-13-33)24-44(22-27-6-8-31(41)9-7-27)52(48,49)37-20-30(39)19-36(40)38(37)45/h4-20,25,45H,21-24H2,1-3H3
- InChiKey:
JKFIWXNQQWRMDC-UHFFFAOYSA-N
External links
58531446 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 8 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 8.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 788.14 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 9.70 | |||
TPSA | 104.22 | |||
RB | 12 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 8 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.00 | |
WO2009152082 | 8 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.40 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5152 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4880 | Evatanepag | DB12022 | |
0.4527 | Vidupiprant | DB12272 | |
0.4500 | (1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE | DB08170 | |
0.4483 | Elsulfavirine | DB14929 | |
0.4462 | CGS-27023 | DB07556 | |
0.4444 | Glyburide | DB01016 | |
0.4350 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4301 | Taprenepag | DB12623 | |
0.4242 | Repinotan | DB06506 | |
0.4187 | Avagacestat | DB11893 | |
0.4130 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4096 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.4085 | AL5927 | DB03526 | |
0.4028 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide | DB04180 |